header-image

Antonio M. Gotto, JR, MD, DPHIL

Antonio M. Gotto, Jr., MD, DPhil, is Dean Emeritus of Weill Cornell Medical College in New York, New York, where he is also the Provost for Medical Affairs Emeritus of Cornell University. From 1997-2011, Dr. Gotto was the Stephen and Suzanne Weiss Dean at Weill Cornell and Provost for Medical Affairs at Cornell University. During his tenure, the Medical College saw an overhaul of its curriculum; record-setting fundraising campaigns; a renaming in honor of foremost benefactors Joan and Sanford Weill; the establishment of a branch campus in Qatar and of a medical school in Tanzania; affiliation with the Methodist Hospital in Houston; and the development of state-of-the-art facilities including the Weill Greenberg Center and the Belfer Research Building, which will double the institution's lab space when it's completed at the end of 2013.  Previously, at Baylor College of Medicine in Houston, Texas, Dr. Gotto was the Bob and Vivian Smith Professor and Chairman of the Department of Medicine, Scientific Director of the DeBakey Heart Center, and the JS Abercrombie Chair for Atherosclerosis and Lipoprotein Research. He also served as Chief of the Internal Medicine Service at The Methodist Hospital in Houston.

Dr. Gotto’s postgraduate work included doctoral studies at Oxford University in England, as a Rhodes Scholar, and residency training at the Massachusetts General Hospital in Boston, Massachusetts. In the field of atherosclerosis, his basic science research interests include clinical disorders of lipid transport and the structure, metabolism, and function of lipoproteins and apolipoproteins. He and his associates were the first to achieve complete synthesis of a plasma apolipoprotein (apo C-I); they also determined the complete cDNA and amino acid sequence of apo B-100, one of the largest proteins ever sequenced and a key protein in atherosclerosis. In addition, Dr. Gotto has played a leading role in several landmark clinical trials demonstrating that cholesterol-lowering drug treatment can reduce the risk for heart disease.

As a lifelong supporter of educational efforts aimed at cardiovascular risk reduction, Dr. Gotto has been National President of the American Heart Association and President of the International Atherosclerosis Society. He is a member of the Institute of Medicine and the American Academy of Arts and Sciences and a recipient of many honors, including the Gold Heart Award from the American Heart Association, the Distinguished Alumnus award from Vanderbilt University and the Vanderbilt University School of Medicine, the Order of the Lion from the Republic of Finland, the International Okamoto Award from the Japan Vascular Disease Research Foundation, the Austrian Cross of Honor for Science and Art First Class, the Maurice R. Greenberg Distinguished Service Award from NewYork-Presbyterian/Weill Cornell, the Distinguished Achievement Award from the National Lipid Association, and the Pasarow Foundation Award in Cardiovascular Research. He has received honorary doctoral degrees from the University of Bologna and Abilene Christian University, honorary professorships from the University of Buenos Aires and Francisco Marroquin University (Guatemala), and he is an Honorary Member of the Society for Progress in Internal Medicine (Ludwig Heilmeyer Society) in Germany.

Dr. Gotto speaks nationally and internationally on cardiovascular disease and has contributed more than 500 scholarly articles and books to the medical literature. In addition, he is coauthor of a series of books that explain the origins and treatment of cardiovascular disease to the general public.